A detailed history of E. Ohman J:Or Asset Management Ab transactions in Arvinas, Inc. stock. As of the latest transaction made, E. Ohman J:Or Asset Management Ab holds 29,830 shares of ARVN stock, worth $569,156. This represents 0.02% of its overall portfolio holdings.

Number of Shares
29,830
Previous 24,830 20.14%
Holding current value
$569,156
Previous $661 Million 11.16%
% of portfolio
0.02%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

BUY
$23.66 - $32.73 $118,300 - $163,649
5,000 Added 20.14%
29,830 $735 Million
Q2 2024

Aug 13, 2024

BUY
$24.46 - $40.4 $112,540 - $185,880
4,601 Added 22.74%
24,830 $661 Million
Q1 2024

May 14, 2024

SELL
$36.38 - $52.31 $264,518 - $380,346
-7,271 Reduced 26.44%
20,229 $835 Million
Q4 2023

Feb 15, 2024

BUY
$14.19 - $42.33 $390,225 - $1.16 Million
27,500 New
27,500 $1.13 Billion

Others Institutions Holding ARVN

About ARVINAS, INC.


  • Ticker ARVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,205,300
  • Market Cap $1.02B
  • Description
  • Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...
More about ARVN
Track This Portfolio

Track E. Ohman J:Or Asset Management Ab Portfolio

Follow E. Ohman J:Or Asset Management Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of E. Ohman J:Or Asset Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on E. Ohman J:Or Asset Management Ab with notifications on news.